(Press-News.org) Mount Sinai Health System announced today that “Mount Sinai Fuster Heart Hospital” is the new name for its top-ranked heart service, formerly known as Mount Sinai Heart. The renaming honors Valentin Fuster, MD, PhD, Physician-in-Chief of The Mount Sinai Hospital and President of the Fuster Heart Hospital, for the immeasurable impact that he has made and will continue to make on the field of cardiology and his leadership at Mount Sinai.
Over the last 25 years, Dr. Fuster has transformed Mount Sinai’s heart service into a world-leading center for cardiovascular disease, providing exceptional and compassionate care for cardiac patients, new and innovative therapies for cardiovascular disease, and local and global health programs to combat heart disease. His legacy continues at the Mount Sinai Fuster Heart Hospital.
“I am grateful for this honor, and proud of my life’s work at Mount Sinai,” says Dr. Fuster. “I can think of nothing more fulfilling than contributing to the understanding, prevention, and treatment of cardiovascular disease, the No. 1 killer worldwide.”
“Our faculty has made great strides in these efforts but we have more work to do to address the challenge of creating a global ‘culture of health’ that ends deadly cardiovascular disease,” Dr. Fuster adds. “We must accelerate the momentum we have already established in this endeavor to advance knowledge and practice for current and future generations of clinicians and researchers. I am proud of what Mount Sinai Heart has achieved, and it is poised to contribute even greater accomplishments, so I am excited for what the future holds.”
The Mount Sinai Fuster Heart Hospital will continue to drive innovation in basic, clinical, and translational cardiovascular research, prioritize patient experience, recruit leading physician-scientists in cardiology, and educate the next generation of physicians to advance levels of cardiac patient care.
It will also continue and expand Dr. Fuster’s decades-long research into the biological, socioeconomic, and environmental mechanisms that affect heart disease. He is pioneering a specialized health education initiative in schools in Harlem and elsewhere in New York City to study the most effective ways to instill healthy habits in children starting at an early age and thereby reduce preventable heart disease and risk factors for the next generation.
Dr. Fuster also helped to create and develop a cardiovascular “polypill”—a single pill that includes three medications typically taken separately—that is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack. Dr. Fuster and his team showed that the polypill reduces cardiovascular mortality by 33 percent in this population. This medication was recently included by the World Health Organization (WHO) in its List of Essential Medicines and is pending Food and Drug Administration approval in the United States.
Under Dr. Fuster’s leadership, The Mount Sinai Hospital ranks No. 1 in New York and No. 4 globally on Newsweek’s list of “The World’s Best Specialized Hospitals.” The Mount Sinai Hospital is also No. 1 in New York for cardiology, cardiac surgery, and vascular surgery, according to U.S. News & World Report®.
His research into the origin of cardiovascular events, which has contributed to improved treatment of heart attack patients, was recognized in 1996 by the Prince of Asturias Award for Technical and Scientific Research (the highest international award given by Spain, Dr. Fuster’s native country). In June 2011 he was awarded the Grand Prix Scientifique of the Institute of France for his translational research into atherothrombotic disease. Recently, he was named a Prince Mahidol Award Laureate in Thailand for his lifelong contribution to the field of medicine, and in 2022, the American College of Cardiology instituted the “Valentin Fuster Award in Science and Innovation,” that will be given to a single physician annually for the next 15 years.
Dr. Fuster has also received the highest awards for research from the four leading cardiovascular organizations: the American Heart Association (Gold Medal and Research Achievement Award), the American College of Cardiology (Living Legend and Life Achievement Award), the European Society of Cardiology (Gold Medal), and the Interamerican Society of Cardiology (Research Achievement Award). In May 2014, King Juan Carlos I of Spain granted Dr. Fuster the title of Marquis for his "outstanding and unceasing research efforts and his educational outreach work."
“Dr. Valentin Fuster is a humanitarian and global champion of cardiovascular health of the first order. His commitment to excellence in research education and to fostering an environment of unparalleled clinical distinction embodies everything for which we strive at Mount Sinai, and as health care providers,” says Kenneth L. Davis, MD, Chief Executive Officer of the Mount Sinai Health System.
“Dr. Fuster’s dedication to interdisciplinary translational research has defined Mount Sinai’s world-leading reputation in cardiovascular care. His groundbreaking contributions to the field have transformed the nature of care for patients well beyond the walls of Mount Sinai. His legacy is one to sustain and emulate at any innovative institution. It is our privilege to have him as our premier ambassador, now and forever.”
Mount Sinai Fuster Heart Hospital is one of the world’s top four hospitals in Cardiology/Heart Surgery
Mount Sinai Fuster Heart Hospital ranks No. 1 in New York and No. 4 globally according to Newsweek’s “The World’s Best Specialized Hospitals.” The Mount Sinai Hospital is also No. 1 in New York for cardiology, cardiac surgery, and vascular surgery, according to U.S. News & World Report®.
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2023-2024.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
###
END
Mount Sinai renames top-ranked heart hospital to honor Valentin Fuster, MD, PhD, and his legacy of excellence
2023-10-26
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Mount Sinai receives $4.6 million from Pershing Square Foundation to support women’s health research and careers for women in science
2023-10-26
(New York, NY – October 26, 2023) – The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from the Pershing Square Foundation to support women’s health research and advance careers for female scientists. Part of an original nearly $21 million gift that expanded a COVID-19 testing program for New York City schools and other organizations, this boost in women-focused initiatives connects the Pershing Square Foundation’s interest in supporting women in science to Mount Sinai’s leading researchers and key initiatives ...
Case Western Reserve University researcher awarded $3.5 million federal grant
2023-10-26
CLEVELAND—A researcher from the Case Western Reserve University Frances Payne Bolton School of Nursing has been awarded a $3.5 million federal grant for research to improve sleep health and glucose management in young adults with type 1 diabetes.
Positive findings could lead to adding the intervention in current care protocols. The ultimate goal is to improve outcomes for a population that struggles to maintain blood-sugar (glycemic) targets, compared to other age groups.
“Young adults with type 1 diabetes are a high-risk group, and I am committed to improving their ...
Study aims to include truckers when redefining trucking in the age of automated vehicles
2023-10-26
AMHERST, Mass. — Last year, trucks moved 73%—11.5 billion tons—of the freight in the U.S., making trucks—and truckers—crucial to the U.S. economy. With automation in trucking projected to grow 22% over the next 10 years, a team of University of Massachusetts Amherst researchers has received a grant to explore how automation will affect the role of American long-haul truckers.
An interdisciplinary group of researchers led by Shannon Roberts, associate professor of mechanical and industrial engineering, has been awarded nearly $2 million over four years by the National Science Foundation’s (NSF) Future of Work Program.
“We know ...
An unexpected link between 2 schizophrenia risk proteins
2023-10-26
COLUMBUS, Ohio – The discovery of a physical interaction between two proteins in brain cells that can be traced in mice to control of movement, anxiety and memory could one day open the door to development of new schizophrenia treatment strategies, researchers say.
The research group is the first to determine that the two proteins, both among the dozens of proteins related to risk for the development of schizophrenia, bind to each other under normal conditions in multiple regions of the brain, ...
ERC Synergy Grants back 37 teams to tackle complex scientific questions
2023-10-26
Thirty-seven research groups will receive €395 million in total to address some of the world’s most formidable research problems spanning a range of scientific disciplines. The funding helps groups of outstanding researchers to pool different skills, knowledge and resources to push the frontiers of our knowledge. The ERC Synergy Grant scheme is part of the EU's research and innovation programme, Horizon Europe.
Iliana Ivanova, Commissioner for Innovation, Research, Culture, Education and Youth, said: “Some scientific questions are too complex to be addressed by researchers working on their own. Challenges such as climate change or ...
New research reveals alarming privacy and security threats in Smart Homes
2023-10-26
An international team of researchers, led by IMDEA Networks and Northeastern University in collaboration with NYU Tandon School of Engineering, Universidad Carlos III de Madrid, IMDEA Software, University of Calgary, and the International Computer Science Institute, has unveiled groundbreaking findings on the security and privacy challenges posed by the ever-growing prevalence of opaque and technically complex Internet of Things (IoT) devices in smart homes.
Smart Homes: Trusted and Secure Environments?
Smart homes are becoming increasingly interconnected, ...
Machine can quickly produce needed cells for cancer treatment
2023-10-26
PULLMAN, Wash. -- A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body’s immune response to target cancer cells.
Washington State University researchers have developed a minifridge-sized bioreactor that is able to manufacture the cells, called T cells, at 95% of the maximum growth rate – about 30% faster than current technologies. The researchers report on their work in the journal Biotechnology Progress. They developed it using T cells from cattle, developed by co-author Bill Davis of WSU’s ...
ERC synergy grant: Multidisciplinary research bridges physics and biology at ISTA and in France
2023-10-26
The Institute of Science and Technology Austria (ISTA) receives its second generous ERC Synergy Grant. ISTA Professor Gašper Tkačik is one of three awarded researchers to join forces on unraveling the secrets of gene regulation during mammalian development.
Three research groups from Austria and France team up to crack open the black box of early mammalian development. Now endowed with a prestigious Synergy Grant from the European Research Council (ERC), Gašper Tkačik (ISTA), Thomas Gregor (Institut Pasteur), ...
A new era for accurate, rapid COVID-19 testing
2023-10-26
Osaka, Japan – A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus’ hold over our society. Now, in an article published in Lab on a Chip, Japanese researchers have developed a promising solution: a novel platform that couples nanopore technology with artificial intelligence.
What is a nanopore? A nanopore is a miniscule hole in a thin substrate, often a silicon wafer. A nanopore might range from several nanometers to several hundred nanometers in diameter — a scale small enough to work with SARS-CoV-2, the virus that causes ...
75% of exclusive hardwood may be illegally harvested
2023-10-26
The tropical wood type ipê is popular for building exclusive wooden decks, and in North America and Europe, the demand for the material has increased sharply. Now, a study from Chalmers University of Technology, Sweden, shows that more than three-quarters of all ipê from the top producing region in Brazil could have been harvested illegally. "The study reveals where in the chain the greatest risks lie. It can be a tool to counteract illegal logging," says Caroline S.S. Franca, PhD student at Chalmers.
Ipê is one of the world's hardest woods. It is therefore particularly suitable for building ...